ParkwayLife REIT DPU History & Dividend Guide 2026 (SGX: C2PU)
FY2025 DPU: 15.29¢ (+2.5% YoY) | 1Q2026 DPU: 4.42¢ (+15.1% YoY) | 18 consecutive years of uninterrupted DPU growth since IPO in 2007. Not financial advice. Data as at May 2026.
ParkwayLife REIT (SGX: C2PU) is widely regarded as one of Singapore’s most reliable dividend payers — and for good reason. Since its IPO in August 2007, it has grown its Distribution Per Unit (DPU) every single year, compounding from 6.32 cents to 15.29 cents in FY2025, representing cumulative growth of 141.9%.
For Singapore investors focused on passive income, healthcare REITs like PLife REIT offer a rare combination: defensive lease structures, CPI-linked rent uplifts, and low gearing. In 1Q2026, DPU surged 15.1% year-on-year to 4.42 cents — the biggest quarterly jump in years — driven by the end of Singapore hospital rent rebates and a new CPI-linked formula that kicks in from FY2026.
This guide covers ParkwayLife REIT’s complete DPU history (FY2017–FY2025), 1Q2026 results, yield analysis, peer comparison, and whether it deserves a place in your CPF or SRS portfolio.
Table of Contents
1. What Is ParkwayLife REIT?
ParkwayLife Real Estate Investment Trust (PLife REIT) is Asia’s largest listed healthcare real estate investment trust by asset size, listed on the Singapore Exchange (SGX: C2PU) since August 2007. It is sponsored by IHH Healthcare Berhad — one of the world’s largest healthcare groups by market capitalisation.
As at end-FY2025, PLife REIT owns 75 healthcare properties across three countries:
- Singapore: 3 private hospitals (Mount Elizabeth, Gleneagles, Parkway East) — the anchor assets, leased to Parkway Hospitals Singapore on triple-net leases
- Japan: 60 nursing homes and care facilities across various prefectures
- France: 11 nursing homes (acquired 2019–2024) providing EUR-denominated income diversification
Total portfolio value: approximately S$2.46 billion. The REIT’s unique lease structure — master leases with rent review formulas linked to the Singapore Consumer Price Index (CPI) — provides predictable, inflation-protected income growth for Singapore’s three hospitals, which contribute the largest share of NPI.
2. ParkwayLife REIT DPU History: FY2017–FY2025
The table below shows ParkwayLife REIT’s annual DPU from FY2017 to FY2025. Every year shows growth — this is one of only a handful of S-REITs to have never cut its distribution in 18 years.
| Financial Year | Annual DPU (¢) | YoY Growth | Key Driver |
|---|---|---|---|
| FY2017 | 12.43¢ | +3.2% | SG hospitals rent uplift, Japan portfolio growth |
| FY2018 | 12.80¢ | +3.0% | Japan nursing home acquisitions |
| FY2019 | 13.19¢ | +3.0% | France portfolio entry, organic SG growth |
| FY2020 | 13.79¢ | +4.6% | COVID-proof healthcare assets, CPI uplift |
| FY2021 | 14.08¢ | +2.1% | SG hospitals stable, Japan FX headwinds |
| FY2022 | 14.39¢ | +2.2% | Record CPI-linked rent review, France additions |
| FY2023 | 14.77¢ | +2.6% | Record high at the time, Japan nursing growth |
| FY2024 | 14.92¢ | +1.0% | JPY weakness offset by SG CPI uplift |
| FY2025 | 15.29¢ | +2.5% | 18th consecutive year of DPU growth |
Sources: ParkwayLife REIT investor relations, SGX announcements. Data as at May 2026.
The standout takeaway: PLife REIT has grown DPU from 6.32¢ at IPO (2007) to 15.29¢ in FY2025 — a cumulative 141.9% increase over 18 years, underpinned by the defensive nature of Singapore’s private hospital leases and disciplined capital recycling in Japan and France.
3. 1Q2026 Results: Why DPU Surged 15.1%
ParkwayLife REIT reported a standout 1Q2026 business update in May 2026, with DPU jumping 15.1% year-on-year to 4.42 cents for the quarter ended 31 March 2026. This was the largest quarterly DPU increase in recent memory — here’s why it happened and why it matters for the rest of 2026.
1Q2026 Key Metrics
| Metric | 1Q2026 | 1Q2025 | YoY Change |
|---|---|---|---|
| Gross Revenue | S$38.2M | S$39.0M | -2.1% |
| Net Property Income (NPI) | S$35.8M | S$36.8M | -2.7% |
| DPU | 4.42¢ | 3.84¢ | +15.1% |
| Portfolio Occupancy | 96.9% | 98.6% | -1.7pp |
Why Did Revenue Dip but DPU Surge?
The apparent contradiction — revenue falling while DPU surged — has a clear explanation:
- Singapore CPI-linked rent review (new formula from FY2026): The new rent review formula for the three Singapore hospitals, which no longer includes a three-year rent rebate given by the hospitals, resulted in a significantly higher effective rent. This is the primary driver of the DPU jump.
- Japan FX headwinds: JPY depreciation against SGD reduced JPY-denominated income when translated back to SGD, pulling gross revenue lower despite stable operational performance in Japan.
- France contributing steady EUR income: The French nursing home portfolio provided stable EUR-denominated distributions as a partial buffer.
The key takeaway for investors: the DPU uplift from Singapore’s new rent formula is structural and recurring, not a one-time boost. This sets a higher DPU base going into FY2026.
4. Yield Analysis & Valuation
At a share price of approximately S$4.02 (as at May 2026), ParkwayLife REIT offers the following yield profile:
| Basis | DPU | Yield at S$4.02 |
|---|---|---|
| FY2025 (historical) | 15.29¢ | 3.80% |
| FY2026 (consensus forecast) | ~17.00–18.00¢ | ~4.2–4.5% |
| 1Q2026 annualised (4.42¢ × 4) | ~17.68¢ | ~4.4% |
PLife REIT has traditionally traded at a premium to other S-REITs due to its defensive characteristics, unbroken DPU growth track record, and IHH Healthcare sponsorship. Its trailing yield of ~3.8% is lower than industrial or commercial S-REITs (which often yield 5–7%), but investors pay a premium for quality and consistency.
Analyst Consensus Target Price
As at May 2026, the analyst consensus target price for PLife REIT is approximately S$4.90, implying ~22% upside from S$4.02. Most coverage is from DBS, UOB Kay Hian, and Citi — all with Buy or Outperform ratings. The FY2026 DPU step-up is seen as a key re-rating catalyst.
Balance Sheet Health
- Gearing ratio: 33.4% (well below MAS’ 50% regulatory cap) — one of the lowest among S-REITs
- Interest coverage: Conservative debt management with hedged debt profile
- Minimum rent uplift: Singapore hospitals provide a minimum 24.3% rent increase baked in for FY2026 under the new CPI-linked formula
5. Peer Comparison: How Does PLife REIT Stack Up?
PLife REIT operates in a niche segment — Singapore has no direct pure-play healthcare REIT peer. For comparison, we look at healthcare-adjacent S-REITs and the broader landscape:
| REIT | Yield (FY2025) | Gearing | DPU Track Record |
|---|---|---|---|
| ParkwayLife REIT (C2PU) | ~3.8% | 33.4% | 18 consecutive years ✓ |
| CapitaLand Ascendas REIT (CLAR) | ~6.1% | 39.0% | Industrial/logistics diversified |
| Mapletree Industrial Trust (MIT) | ~6.5% | 34.0% | Data centres + industrial |
| Sabana REIT | ~7.5% | 37.8% | Industrial, higher yield/risk |
| AIMS APAC REIT (AA REIT) | ~6.9% | 26.8% | Industrial/logistics SG+AU |
PLife REIT offers a lower yield than industrial peers — but this is the “quality premium”. Healthcare leases are triple-net (tenants bear operating costs), CPI-linked, and backed by Singapore’s top private hospital group. The risk-reward profile is markedly different from an industrial REIT exposed to trade and tariff cycles.
For investors who prioritise DPU stability and capital preservation over maximum yield, PLife REIT is often the top pick. For those who want higher current income, consider pairing it with a higher-yielding industrial REIT — see our Best S-REITs Singapore 2026 guide for portfolio construction ideas.
6. Portfolio Overview: Singapore, Japan & France
PLife REIT’s 75-property portfolio is structured around three anchor markets, each with distinct roles in the income profile:
Singapore (3 Hospitals) — The Income Engine
The three Singapore private hospitals — Mount Elizabeth Hospital, Gleneagles Hospital, and Parkway East Hospital — are leased to Parkway Hospitals Singapore Pte Ltd on long-term triple-net master leases. These leases include rent reviews every three years, with the new formula from FY2026 delivering a minimum 24.3% uplift in base rent. Despite contributing only three properties, the Singapore hospitals generate the largest proportion of NPI due to their scale and premium positioning.
Japan (60 Nursing Homes) — The Growth Engine
PLife REIT has steadily expanded its Japan portfolio since 2008, now holding 60 nursing homes and care facilities across key prefectures. Japan’s ageing demographic — 30% of the population is over 65 — creates structural demand for quality aged care. However, JPY/SGD currency risk is a key watchpoint: yen weakness in 2023–2025 reduced SGD-translated income despite stable JPY-denominated performance.
France (11 Nursing Homes) — The Diversification Buffer
Acquired between 2019 and 2024, the 11 French nursing homes provide EUR-denominated income and geographic diversification. France’s state-backed healthcare system provides tenant credit quality, though EUR/SGD movements add currency exposure.
Overall portfolio committed occupancy was 96.9% as at 1Q2026 (down from 98.6% at FY2025 year-end, largely reflecting Japan tenant transitions). The Singapore hospitals remain at near-100% occupancy given their anchor tenant structure.
7. How to Buy ParkwayLife REIT (CPF & SRS Eligible)
PLife REIT (SGX: C2PU) is listed on the mainboard of the Singapore Exchange and is fully eligible for purchase using CPF Investment Scheme (CPFIS-OA) and Supplementary Retirement Scheme (SRS) funds.
Buying via CPF (CPFIS-OA)
- You must have more than S$20,000 in your CPF OA (only amounts above S$20,000 can be invested under CPFIS)
- Open a CPFIS-approved brokerage account (DBS Vickers, OCBC Securities, FSMOne, UOB Kay Hian)
- Buy C2PU on SGX through your brokerage — CPF funds are automatically deducted
- Note: CPF OA currently earns 2.5% p.a. guaranteed — PLife REIT’s forward yield of ~4.2–4.5% exceeds this, making it an attractive CPFIS candidate for investors comfortable with price volatility
Buying via SRS
- Fund your SRS account at DBS, OCBC, or UOB (annual SRS contribution cap: S$15,300 for Singapore citizens/PRs)
- Use your SRS funds to purchase C2PU on SGX — dividends received go back into your SRS account
- SRS contributions reduce taxable income in the year of contribution, providing an upfront tax benefit
Platforms to Consider
For the lowest brokerage fees when buying S-REITs, consider FSMOne (CDP-linked, flat S$10 or 0.08% min) or Syfe REIT+ which holds a basket of top S-REITs including PLife REIT exposure. For direct share ownership with CPF, Endowus allows CPF fund investing in eligible unit trusts that may include PLife REIT.
Use our free S-REIT Dividend Yield Calculator to model your expected annual income from PLife REIT at different entry prices and holding sizes. You can also check our S-REIT Yield vs SGS Bond Spread Calculator to assess current valuation vs the risk-free rate.
8. Key Risks to Watch
Despite its stellar track record, PLife REIT is not risk-free. Here are the main factors Singapore investors should monitor:
- JPY/SGD currency risk: Japan contributes ~40% of properties by count. A weakening yen directly reduces SGD-translated NPI and DPU from Japanese assets. The REIT does use currency hedging tools but residual exposure remains.
- EUR/SGD currency risk: Similar exposure from the 11 French nursing homes. A strengthening SGD vs EUR reduces income.
- Sponsor concentration: The three Singapore hospitals are leased to a single tenant (Parkway Hospitals Singapore, an IHH subsidiary). Any deterioration in IHH’s financial position or lease negotiation could impact income.
- Valuation premium risk: PLife REIT typically trades at a premium to book value. If interest rates rise sharply, the valuation re-rates downward even if DPU is stable.
- Japan nursing home sector headwinds: Rising operating costs (insurance, labour, energy) in Japan could pressure tenant profitability, potentially affecting lease renewals.
- France regulatory risk: French healthcare regulations and government reimbursement rates affect tenant profitability and occupancy.
For broader S-REIT risk context, see our S-REIT Outlook 2026 guide and the Best S-REITs Singapore 2026 comparison.
Invest in S-REITs with the Right Platform
Ready to buy ParkwayLife REIT or build a diversified S-REIT portfolio? Use one of these Singapore platforms:
FAQ: ParkwayLife REIT DPU & Dividends
What is ParkwayLife REIT's DPU for FY2025?
How often does ParkwayLife REIT pay dividends?
What is ParkwayLife REIT's dividend yield in 2026?
Why did ParkwayLife REIT's 1Q2026 DPU surge 15.1%?
Can I buy ParkwayLife REIT using CPF?
Is ParkwayLife REIT SRS-eligible?
What is ParkwayLife REIT's gearing ratio?
How does ParkwayLife REIT compare to other healthcare REITs in Asia?
Related S-REIT Guides on The Kopi Notes
- Best S-REITs Singapore 2026: Yield Comparison Table
- S-REIT Outlook 2026: Rate Cuts & Best Picks
- ParkwayLife REIT Share Price & Investor Guide 2026
- Singapore REIT ETF Guide: Lion-Phillip S-REIT ETF vs Nikko AM
- Free S-REIT Dividend Yield Calculator
Disclaimer: This article is for informational purposes only and does not constitute financial advice. All investments carry risk. Past DPU performance does not guarantee future distributions. Please consult a licensed financial adviser before making investment decisions.